Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line

Cancer Research

Volumn 59, Issue 5, 1999, Pages 1134-1140

  Coco Martin, José M ^a   Balkenende, Astrid ^b   Verschoor, Tom ^b   Lallemand, Francois ^b   Michalides, Rob ^b  

^a Division of Experimental Therapy   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1;

APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER SURVIVAL; CELL CYCLE G1 PHASE; CYTOSTASIS; DNA CONTENT; ENZYME PHOSPHORYLATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION INJURY; RADIOSENSITIVITY;

APOPTOSIS; BREAST NEOPLASMS; CELL SURVIVAL; CYCLIN D1; FEMALE; FLOW CYTOMETRY; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINETICS; RADIATION TOLERANCE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0001443049     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Lammie, G. A., Fantl, V., Smith, R., Schuuring, E., Brookcs, S., Michalides, R., Dickson, C., Arnold, A., and Peters, G. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene. 6: 439-444, 1991.
2. Barbara, F., Cagnoli, M., Ragni, N., Pedulla, F., Foglia, G., and Alama, A. Expression of cyclin D1 correlates with malignancy in human ovarian tumours. Br. J. Cancer. 75: 1263-1268, 1997.
3. Michalides, R. J., Van Veelen, N., Hart, A., Loftus, B., Wientjens, E., and Balm, A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res. 55: 975-978, 1995.
4. Lidereau, R., Callahan, R., Dickson, C., Peters, G., Escot, C., and Ali, I. U. Amplification of the int-2 gene in primary human breast tumors. Oncogene Res. 2: 285-291, 1988.
5. Tsuda, H., Hirohashi, S., Shimosato, Y., Hirota, T., Tsugane, S., Yamamoto, H., Miyajima, N., Toyoshima, K., Yamamoto, T., and Yokota, J. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res., 49: 3104-3108, 1989.
6. Borg, A., Sigurdsson, H., Clark, G. M., Ferno, M., Fuqua, S. A., Olsson, H., Killander, D., and McGurie, W. L. Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br. J. Cancer. 63: 136-142, 1991.
7. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
8. 1 checkpoint. Mol. Cell. Biol., 16: 6917-6925, 1996.
9. 1 phase cyclins and cyclin-dependent kinase inhibitors. Trends Cell Biol., 7: 348-352, 1997.
10. Sherr, C. J., and Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
11. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell. 88: 323-331, 1997.
12. Liu, Y., Martindale, J. L., Gorospe, M., and Holbrook, N. J. Regulation of p21WAFI/ CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res., 56: 31-35, 1996.
13. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9: 935-944, 1995.
14. Hiyama, H., Iavarone, A., LaBaer, J., and Reeves, S. A. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene. 14: 2533-2542, 1997.
15. Hiyama, H., Iavarone, A., and Reeves, S. A. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene. 16: 1513-1523, 1998.
16. LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., and Harlow, E. New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11: 847-862, 1997.
17. Blain, S. W., Montalvo, E., and Massague, J. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem., 272: 25863-25872, 1997.
18. Doki, V., Imoto, M., Han, E. K., Sgambato, A., and Weinstein, I. B. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis (Lond.), 18: 1139-1148, 1997.
19. Han, E. K., Begemann, M., Sgambato, A., Sob, J. W., Doki, Y., Xing, W. Q., Liu, W., and Weinstein, I. B. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ., 7: 699-710, 1996.
20. 2 phase: regulation of the γ-irradiation-induced delay and DNA repair. Oncogene, 15: 2597-2607, 1997.
21. Zwijsen, R. M., Klompmaker, R., Wientjens, E. B., Kristel, P. M., Van der Burg, B., and Michalides, R. J. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol. Cell. Biol., 16: 2554-2560, 1996.
22. Parry, D., Bates, S., Mann, D. J., and Peters, G. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J., 14: 503-511, 1995.
23. Begg, A. C., and Holland, I. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry. Cytometry, 12: 445-154, 1991.
24. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. S. Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
25. Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kato, J. Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14: 2066-2076, 1994.
26. 1 accumulation after 2 Gy of gamma-irradiation is related to endogenous Raf-1 protein expression and intrinsic radiosensitivity in human cells. Br. J. Cancer. 77: 1220-1228, 1998.
27. Pellegata, N. S., Antonio, R. J., Redpalh. J. L., and Stanbridge, E. J. DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc. Natl. Acad. Sci. USA, 93: 15209-15214, 1996.
28. Donaldson, K. L., Goolsby, G. L., Kiener, P. A., and Wahl, A. F. Activation of p34cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ., 5: 1041-1050, 1994.
29. Fornari, F. A., Jr., Jarvis, W. D., Grant, S., Orr, M. S., Randolph, J. K., White, F. K., Mumaw, V. R., Lovings, E. T., Freeman, R. H., and Gewirtz, D. A. Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin. Cell Growth Differ., 5: 723-733, 1994.
30. Oberhammer, F., Wilson, J. W., Dive, C., Morris, I. D., Hickman, J. A., Wakeling, A. E., Walker, P. R., and Sikorska, M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J., 12: 3679-3684, 1993.
31. Gossen, M. and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 89: 5547-5551, 1992.
32. Sumantran, V. M., Ealovega, M. W., Nunez, G., Clarke, M. F., and Wicha, M. S. Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res., 55: 2507-2510, 1995.
33. Kranenhurg, O., van der Eb, A. J., and Zantema, A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J., 15: 46-54, 1996.
34. 1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA, 91: 8022-8026, 1994.
35. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol., 14: 1669-1679, 1994.
36. Sofer-Levi, Y., and Resnitzky, D. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene. 13: 2431-2437, 1996.
37. Gillett, C., Smith, P., Gregory, W., Richards, M., Millis, R., Peters, G., and Barries, D. Cyclin D1 and prognosis in human breast cancer. Int. J. Cancer. 69: 92-99, 1996.
38. Michalides, R., Hageman, P., van Tinteren, H., Houben, L., Wientjens, E., Klompmaker, R., and Peterse, H. A clinico-pathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br. J. Cancer. 73: 728-734, 1996.
39. Hain, J., Weller, E. M., Jung, T., and Burkart, W. Effects of ionizing- and UV B-radiation on proteins controlling cell cycle progression in human cells: comparison of the MCF-7 adenocarcinoma and the SCL-2 squamous cell carcinoma cell line. Int. J. Radiat. Biol., 70: 261-271, 1996.
40. 2/M-phase transition. Mol. Cell. Biol., 18: 546-557, 1998.
41. Weintraub, S. J., Prater, C. A., and Dean, D. C. Retinoblastoma protein switches the E2F site from positive to negative element. Nature (Lond.), 358: 259-261, 1992.
42. 1-S arrest in p53+ human tumor cells synchronized by mitotic selection. Cancer Res., 58: 2036-2041, 1998.
43. Biagosklonny, M. V., and El-Deiry, W. S. Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. Int. J. Cancer. 75: 933-940, 1998.
44. 1/S-phase transition. Radiat. Res., 143: 245-254, 1995.
45. Biagosklonny, M. V., Schulte, T., Nguyen, P., Trepel, J., and Neckers, L. M. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res., 56: 1851-1854, 1996.
46. Haldar, S., Chintapalli, J., and Croce, C. M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56: 1253-1255, 1996.
47. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80: 293-299, 1995.
48. 1/S checkpoint following ionizing radiation irradiation. Somat. Cell Mol. Genet. 22: 135-144, 1996.